The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With ...

BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses the concept of an immune reset and what the company is tracking in ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

RENTON, Wash. — The 61-year-old man charged with killing a Renton salon owner in February 2024 is back in King County after ...

That time of year is almost upon us, when millions of people in the UK succumb to pollen-induced sneezes, sniffles and itchy ...

Corderius Johnson has been charged with second-degree murder in connection with the death of Joseph Hamilton. Johnson said ...

Zemoso Labs has shown its immense impact as a global leader in innovation, driving startup success and enterprise growth ...

I am a 71-year-old male who is a nonsmoker and a social drinker. Other than a statin, I am not taking any medications. I have been getting colonoscopies ...

State Lawmakers and leaders of education committees in Oklahoma City said there is a lot of movement towards improving the ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.Researchers have taken a major step ...